[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349756-105":59,"doc-detail-349756-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","radiolabelled-fapi-radiotracers-in-oncology-a-comprehensive-review-of-current-diagnostic-and-emerging-therapeutic-applications","Radiolabelled FAPI Radiotracers in Oncology - A Comprehensive Review of Current Diagnostic and Emerging Therapeutic Applications","","Fibroblast activation protein (FAP) is highly expressed in cancer-associated fibroblasts (CAFs) across many epithelial malignancies, making it a promising target for molecular imaging and radionuclide therapy. This comprehensive review synthesizes current evidence on radionuclide-labelled FAP inhibitors (FAPIs), emphasizing diagnostic utility, emerging therapeutic applications, and structural determinants of biological behavior. A structured search across PubMed, Scopus, and Web of Science supports findings of strong tumour-to-background contrast for 68Ga- and 18F-labelled tracers and clinically relevant theranostic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/radiolabelled-fapi-radiotracers-in-oncology-a-comprehensive-review-of-current-diagnostic-and-emerging-therapeutic-applications/349756/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/radiolabelled-fapi-radiotracers-in-oncology-a-comprehensive-review-of-current-diagnostic-and-emerging-therapeutic-applications/349756.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What makes FAP a target for molecular imaging and radionuclide therapy in oncology?","Question",{"text":112,"@type":113},"FAP is abundantly expressed in cancer-associated fibroblasts (CAFs) across multiple epithelial malignancies. Its high expression supports its use as a molecular target for both imaging and radiotherapy approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What diagnostic performance do radiolabelled FAPI tracers show in the reported studies?",{"text":117,"@type":113},"Diagnostic studies demonstrate high tumour-to-background contrast for [68Ga]Ga and [18F]-labelled FAPI radiotracers. FAPI PET/CT can show better lesion conspicuity than [18F]FDG in specific anatomical sites such as the brain, liver, and peritoneum.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic directions are highlighted for FAPI-based radiotracers?",{"text":121,"@type":113},"Therapeutic evidence indicates encouraging tumour retention and safety for agents such as [177Lu]Lu-FAP-2286 and [90Y]Y-FAPI-46. Preclinical work also suggests potent antitumor effects for alpha-emitting radiotracers like [225Ac]Ac-FAPI-04.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349756,1791127997,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \nRadiolabelled FAPI Radiotracers in Oncology: A Comprehensive Review of Current Diagnostic and Emerging  \nTherapeutic Applications  \nJolanta Czuczejko 1,2, *, Bogdan Małkowski 3, Jarosław Nuszkiewicz 4, Iga Hoły ´nska-Iwan 5,  \nPaweł Wa´sniowski 1,6, Katarzyna Ma˛dra-Gackowska 7, Wiktor Dród 2 and Karolina Szewczyk-Golec 4, *  \nAcademic Editor: Junbo Zhang  \nReceived: 1 December 2025  \nRevised: 27 December 2025  \nAccepted: 29 December 2025  \nPublished: 2 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Nuclear Medicine Department, Oncology Centre-Prof. Franciszek Łukaszczyk Memorial Hospital,  \n2 Dr I. Romanowskiej St., 85-796 Bydgoszcz, Poland; [pawel.wasniowski@cm.umk.pl](pawel.wasniowski@cm.umk.pl)  \n2 Department of Psychiatry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, 9 M. Curie Skłodowskiej St., 85-094 Bydgoszcz, Poland; [wikdr@cm.umk.pl](wikdr@cm.umk.pl)  \n3 Department of Diagnostic Imaging, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, 2 Dr I. Romanowskiej St., 85-796 Bydgoszcz, Poland; [malkowskib@co.bydgoszcz.pl](malkowskib@co.bydgoszcz.pl)  \n4 Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, 24 Karłowicza St., 85-092 Bydgoszcz, Poland; [jnuszkiewicz@cm.umk.pl](jnuszkiewicz@cm.umk.pl)  \n5 Laboratory of Electrophysiology of Epithelial Tissue and Skin, Department of Pathobiochemistry and Clinical Chemistry, Faculty of Pharmacy, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, 9 M. Curie Skłodowskiej St., 85-094 Bydgoszcz, Poland; [igaholynska@cm.umk.pl](igaholynska@cm.umk.pl)  \n6 Department of Electroradiology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, Sandomierska 16 St., 85-830 Bydgoszcz, Poland  \n7 Department of Geriatrics, Faculty of Health Sciences, L. Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru ´n, Skłodowskiej Curie 9 St, 85-094 Bydgoszcz, Poland; [katarzyna.madra@cm.umk.pl](katarzyna.madra@cm.umk.pl)  \n* [Correspondence: joczu@cm.umk.pl](Correspondence: joczu@cm.umk.pl) (J.C.); [karosz@cm.umk.pl](karosz@cm.umk.pl) (K.S.-G.)  \nAbstract  \nBackground/Objectives: Fibroblast activation protein (FAP), which is abundantly expressed in cancer-associated fibroblasts (CAFs) across various epithelial malignancies, has emerged as a promising target for molecular imaging and radionuclide therapy. Although several reviews have addressed FAP-targeted diagnostics, a comprehensive synthesis integrating molecular biology, diagnostic performance, and early therapeutic development remains limited. This review summarises the current evidence on radionuclide-labelled FAP inhibitors (FAPIs), with particular emphasis on their diagnostic utility, emerging therapeutic applications, and the structural features that shape their biological behaviour. Methods: A structured literature search was conducted across PubMed, Scopus, and Web of Science, focusing on FAPI-based imaging and therapy. Results: Diagnostic studies consistently demonstrate high tumour-to-background contrast for [68Ga]Ga and [18F]-labelled FAPI radiotracers, particularly in tumours with prominent stromal components such as pancreatic, colorectal, breast, and head and neck cancers. FAPI PET/CT often surpasses [18F]FDGin lesion conspicuity in the brain, liver, and peritoneum. Therapeutic evidence shows encouraging tumour retention and safety profiles for agents such as [177Lu]Lu-FAP-2286 and [90Y]Y-FAPI-46, while α-emitting radiotracers (e.g., [225Ac]Ac-FAPI-04) demonstrate potent antitumor effects in preclinical models. Conclusions: Radio","cbCaiq9nFNDLjME5","https://ap.wps.com/l/cbCaiq9nFNDLjME5","pdf",703104,21,"English","# Abstract\n# 1. Introduction\n## 1.1. Biology and Function of CAFs","[{\"question\":\"What makes FAP a target for molecular imaging and radionuclide therapy in oncology?\",\"answer\":\"FAP is abundantly expressed in cancer-associated fibroblasts (CAFs) across multiple epithelial malignancies. Its high expression supports its use as a molecular target for both imaging and radiotherapy approaches.\"},{\"question\":\"What diagnostic performance do radiolabelled FAPI tracers show in the reported studies?\",\"answer\":\"Diagnostic studies demonstrate high tumour-to-background contrast for [68Ga]Ga and [18F]-labelled FAPI radiotracers. FAPI PET/CT can show better lesion conspicuity than [18F]FDG in specific anatomical sites such as the brain, liver, and peritoneum.\"},{\"question\":\"What therapeutic directions are highlighted for FAPI-based radiotracers?\",\"answer\":\"Therapeutic evidence indicates encouraging tumour retention and safety for agents such as [177Lu]Lu-FAP-2286 and [90Y]Y-FAPI-46. Preclinical work also suggests potent antitumor effects for alpha-emitting radiotracers like [225Ac]Ac-FAPI-04.\"}]","Radiolabelled FAPI Radiotracers in Oncology - A Comprehensive Review of Current Diagnostic and Emerging Therapeutic Applications | PDF",1790085414,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52a6753ddfa721d2f7dbed5233ed18c8.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/545d16e6dcf6630b009d78bffe597fbb.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f80328eccd69079be1e7f76f2b912e0e.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2e3e3c91f41c941a83a22092fc17c3b.webp",980,1385]